Nanoparticles for topical application in the treatment of skin dysfunctions—an overview of dermo-cosmetic and dermatological products
M Raszewska-Famielec, J Flieger - International Journal of Molecular …, 2022 - mdpi.com
Nanomaterials (NM) arouse interest in various fields of science and industry due to their
composition-tunable properties and the ease of modification. They appear currently as …
composition-tunable properties and the ease of modification. They appear currently as …
The interleukin-8 pathway in cancer
DJJ Waugh, C Wilson - Clinical cancer research, 2008 - AACR
Abstract Interleukin-8 (IL-8) is a proinflammatory CXC chemokine associated with the
promotion of neutrophil chemotaxis and degranulation. This chemokine activates multiple …
promotion of neutrophil chemotaxis and degranulation. This chemokine activates multiple …
[HTML][HTML] Applications of nanotechnology in dermatology
LA DeLouise - Journal of Investigative Dermatology, 2012 - Elsevier
What are nanoparticles and why are they important in dermatology? These questions are
addressed by highlighting recent developments in the nanotechnology field that have …
addressed by highlighting recent developments in the nanotechnology field that have …
Targeted drug delivery to melanoma
Melanoma derived from melanocytes is the most aggressive genre of skin cancer. Although
the considerable advancement in the study of human cancer biology and drug discovery …
the considerable advancement in the study of human cancer biology and drug discovery …
ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit
BJ Wilson, KR Saab, J Ma, T Schatton, P Pütz, Q Zhan… - Cancer research, 2014 - AACR
The drug efflux transporter ABCB5 identifies cancer stem–like cells (CSC) in diverse human
malignancies, where its expression is associated with clinical disease progression and …
malignancies, where its expression is associated with clinical disease progression and …
CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche
Highly metastatic and chemotherapy-resistant properties of malignant melanomas stand as
challenging barriers to successful treatment; yet, the mechanisms responsible for their …
challenging barriers to successful treatment; yet, the mechanisms responsible for their …
Current systemic therapy for metastatic melanoma
SS Agarwala - Expert review of anticancer therapy, 2009 - Taylor & Francis
Metastatic melanoma remains a lethal disease with a long-term remission rate of less than
10%. Despite many years of research, there has not been a new drug approved in this …
10%. Despite many years of research, there has not been a new drug approved in this …
Cytokine profile of conditioned medium from human tumor cell lines after acute and fractionated doses of gamma radiation and its effect on survival of bystander tumor …
Cytokines are known to play pivotal roles in cancer initiation, progression and pathogenesis.
Accumulating evidences suggest differences in basal and stress-induced cytokine profiles of …
Accumulating evidences suggest differences in basal and stress-induced cytokine profiles of …
[HTML][HTML] Adjuvant low-dose interferon α2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma …
C Garbe, P Radny, R Linse, R Dummer, R Gutzmer… - Annals of …, 2008 - Elsevier
Background More than half of patients with melanoma that has spread to regional lymph
nodes develop recurrent disease within the first 3 years after surgery. The aim of the study …
nodes develop recurrent disease within the first 3 years after surgery. The aim of the study …
[HTML][HTML] How to MEK the best of uveal melanoma: A systematic review on the efficacy and safety of MEK inhibitors in metastatic or unresectable uveal melanoma
T Steeb, A Wessely, T Ruzicka, MV Heppt… - European Journal of …, 2018 - Elsevier
Background BRAF and MEK inhibitors have demonstrated significant survival benefits for
patients with cutaneous melanoma. However, their use for uveal melanoma (UM) is less …
patients with cutaneous melanoma. However, their use for uveal melanoma (UM) is less …